Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / John V. Oyler
Person

John V. Oyler

Tracked across 2 events · 13 articles · First seen Aug 10, 2026 · Last active Aug 18, 2026

Sentiment
22
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
2 5
Business
BeOne renews BRUKINSA access partnership
BeOne Medicines, together with the Kashmir Care Foundation and The Max Foundation, announced the renewal of their partnership through 2028 to expand access to BRUKINSA (zanubrutinib) for the treatment of chronic lymphocytic leukemia (CLL) in…
Impact: As CEO of BeOne Medicines, John V. Oyler publicly endorsed the partnership, highlighting the company's goal of ensuring access to cancer care regardless of geography.
Aug 18, 2026 · 6 articles
4 40
Business
BeOne and Revolution Medicines oncology collaboration
BeOne Medicines and Revolution Medicines announced a multi-part collaboration on August 10, 2026. The deal includes a clinical collaboration to evaluate drug combinations combining select BeOne oncology assets with Revolution Medicines' four clinical RAS(ON) inhibitors…
Impact: As CEO of BeOne, Oyler is a key figure in the collaboration, expressing optimism about the deal's potential to bring new medicines to patients.
Aug 10, 2026 · 7 articles
ERGEN INTELLIGENCE
Track John V. Oyler live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.